comparemela.com

Latest Breaking News On - Oncology phase - Page 1 : comparemela.com

Form 20-F KAZIA THERAPEUTICS LTD For: Jun 30

Form 20-F KAZIA THERAPEUTICS LTD For: Jun 30
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

China
Ukraine
Deerfield
New-york
United-states
Seoul
Soult-ukpyolsi
South-korea
Switzerland
France
Gaza
Israel-general

Biomica & Rambam Health Care Campus Sign Agreement for Clinical Trial of Biomica's Microbiome-Based Immuno-Oncology Drug

/PRNewswire/ Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd..

Israel
Laine-yonker
Ruth-perets
Rivka-neufeld
Joseph-green
Elran-haber
Sloan-kettering
Lavie-bio-ltd
Biomica-ltd
Evogene-ltd
Israel-ministry-of-health
Nasdaq

COVID Vaccine may Reduce Platelet Count in the Blood

Idiopathic thrombocytopenic purpura (ITP), a condition that affects the blood by low platelet count, may be associated the Oxford-AstraZeneca COVID vaccine in rare cases.

Australia
Glasgow
Glasgow-city
United-kingdom
Belfast
Bombay
Maharashtra
India
Edinburgh
City-of
Australian
Scotland

COVID-19 Disrupts Oncology Trials

COVID-19 Disrupts Oncology Trials COVID-19 disruptions reveal heavy impacts on the global Oncology Phase II clinical trials, as per GlobalData, a leading data and analytics company. Several factors including delayed initiation, enrollment suspension, and slow enrolment are the known contributing factors for these disruptions. The total number of clinical trials that were disrupted showed that slow enrollment was the top reason, followed by enrollment suspension and lastly delayed initiation as reported by GlobalData s global survey of key opinion leaders in the pharma industry. As there are more clinical trials in oncology, it is not surprising that it is the most disrupted of the therapy areas. The main challenge has been providing the necessary cancer care during the pandemic. Finding the necessary resources such as ventilation systems and even staff is an on-going challenge for most healthcare providers. Globally, North America far exceeds all other countries w

Oncology-phase
Covid-19
Pandemic
Ncology
Covid-19-disruptions
Hase-ii-clinical-trials
Clinical-trials

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.